News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

"Serious Faults" In Novartis Pharma K.K. (NVS) Clinical Study Of Leukemia Drug: Panel


6/26/2014 5:55:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TOKYO (Kyodo) -- Novartis Pharma K.K. violated Japan's personal information protection law and ethical guidelines in a clinical study, led by the University of Tokyo, of a leukemia drug, the university's investigation panel said Tuesday.

Following release of its final report, the university will consider punishing those responsible, a university official said.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES